European Respiratory Review

The European Respiratory Review (ERR) is an open access journal published by the European Respiratory Society (ERS), providing an update on medicine, science and surgery for respiratory professionals. The ERR contains state-of-the-art review articles, editorials and correspondence, in addition to summaries of the most important recent research findings and published studies in topics such as COPD, asthma, pulmonary hypertension, interstitial lung disease, lung cancer, tuberculosis and pulmonary infections. Articles are published continuously and collected into quarterly issues in one volume per year.

December

Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis Inês Rodrigues, Ricardo Estêvão Gomes, Lígia Maria Coutinho, Maria Teresa Rego, Firmino Machado, António Morais, Helder Novais Bastos Eur Respir Rev, 31 (166) 210280; 10.1183/16000617.0280-2021
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Raymond L. Benza, David Langleben, Anna R. Hemnes, Anton Vonk Noordegraaf, Stephan Rosenkranz, Thenappan Thenappan, Paul M. Hassoun, Ioana R. Preston, Stefano Ghio, Roberto Badagliacca, Carmine D. Vizza, Irene M. Lang, Christian Meier, Ekkehard Grünig Eur Respir Rev, 31 (166) 220061; 10.1183/16000617.0061-2022
The effects of COVID-19 on respiratory muscle performance: making the case for respiratory muscle testing and training Richard Severin, Colin K. Franz, Ellen Farr, Cristiane Meirelles, Ross Arena, Shane A. Phillips, Sam Bond, Francesco Ferraro, Mark Faghy Eur Respir Rev, 31 (166) 220006; 10.1183/16000617.0006-2022
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations Georgia Mitropoulou, Angela Koutsokera, Chantal Csajka, Sylvain Blanchon, Alain Sauty, Jean-Francois Brunet, Christophe von Garnier, Grégory Resch, Benoit Guery Eur Respir Rev, 31 (166) 220121; 10.1183/16000617.0121-2022
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis Graeme Prosperi-Porta, Paul Ronksley, Omid Kiamanesh, Kevin Solverson, Pouya Motazedian, Jason Weatherald Eur Respir Rev, 31 (166) 220120; 10.1183/16000617.0120-2022
Respiratory infections Michael S. Niederman, Antoni Torres Eur Respir Rev, 31 (166) 220150; 10.1183/16000617.0150-2022
Respiratory viruses: their importance and lessons learned from COVID-19 Catia Cilloniz, Carlos M. Luna, Juan Carlos Hurtado, María Ángeles Marcos, Antoni Torres Eur Respir Rev, 31 (166) 220051; 10.1183/16000617.0051-2022
How and when to manage respiratory infections out of hospital Rodrigo Cavallazzi, Julio A. Ramirez Eur Respir Rev, 31 (166) 220092; 10.1183/16000617.0092-2022
The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic Daniel Reynolds, Jason P. Burnham, Cristina Vazquez Guillamet, Mikaela McCabe, Valerie Yuenger, Kevin Betthauser, Scott T. Micek, Marin H. Kollef Eur Respir Rev, 31 (166) 220068; 10.1183/16000617.0068-2022
Non-Aspergillus mould lung infections Pedro Puerta-Alcalde, Carolina Garcia-Vidal Eur Respir Rev, 31 (166) 220104; 10.1183/16000617.0104-2022
Circulating tumour cells in patients with lung cancer universally indicate poor prognosis Fukang Jin, Lei Zhu, Jingbo Shao, Mina Yakoub, Lukas Schmitt, Christoph Reißfelder, Sonja Loges, Axel Benner, Sebastian Schölch Eur Respir Rev, 31 (166) 220151; 10.1183/16000617.0151-2022
Virtual consultations for patients with obstructive sleep apnoea: a systematic review and meta-analysis Sulaiman S. Alsaif, Julia L. Kelly, Stuart Little, Hilary Pinnock, Mary J. Morrell, Michael I. Polkey, Phyllis Murphie Eur Respir Rev, 31 (166) 220180; 10.1183/16000617.0180-2022
Respiratory muscle training in neuromuscular disease: a systematic review and meta-analysis Kathryn Watson, Thorlene Egerton, Nicole Sheers, Sarah Retica, Rebekah McGaw, Talia Clohessy, Penny Webster, David J. Berlowitz Eur Respir Rev, 31 (166) 220065; 10.1183/16000617.0065-2022
Inhaled corticosteroids for the treatment of COVID-19 Mona Bafadhel, Rosa Faner, Camille Taillé, Richard E.K. Russell, Tobias Welte, Peter J. Barnes, Alvar Agustí Eur Respir Rev, 31 (166) 220099; 10.1183/16000617.0099-2022
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries Jonathan S. Nguyen-Van-Tam, Maureen O'Leary, Emily T. Martin, Esther Heijnen, Benoit Callendret, Roman Fleischhackl, Christy Comeaux, Thao Mai Phuong Tran, Karin Weber Eur Respir Rev, 31 (166) 220105; 10.1183/16000617.0105-2022
The role of gene–ambient air pollution interactions in paediatric asthma Jelte Kelchtermans, Hakon Hakonarson Eur Respir Rev, 31 (166) 220094; 10.1183/16000617.0094-2022
Extracorporeal carbon dioxide removal in acute hypoxaemic respiratory failure: a systematic review, Bayesian meta-analysis and trial sequential analysis Jonathan E. Millar, Andrew J. Boyle, Thomas M. Drake, Claire E. Adams, Adam W. Glass, Bronagh Blackwood, James J. McNamee, Daniel F. McAuley Eur Respir Rev, 31 (166) 220030; 10.1183/16000617.0030-2022
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis Bang Zheng, Luke Daines, Qing Han, John R. Hurst, Paul Pfeffer, Manu Shankar-Hari, Omer Elneima, Samantha Walker, Jeremy S. Brown, Salman Siddiqui, Jennifer K. Quint, Christopher E. Brightling, Rachael A. Evans, Louise V. Wain, Liam G. Heaney, Aziz Sheikh Eur Respir Rev, 31 (166) 220071; 10.1183/16000617.0071-2022
Clinical significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute exacerbations of COPD: present and future Angelo Zinellu, Elisabetta Zinellu, Arduino A. Mangoni, Maria Carmina Pau, Ciriaco Carru, Pietro Pirina, Alessandro G. Fois Eur Respir Rev, 31 (166) 220095; 10.1183/16000617.0095-2022
Risk of serious COVID-19 outcomes among adults and children with moderate-to-severe asthma: a systematic review and meta-analysis Bohee Lee, Grace Lewis, Eldad Agyei-Manu, Nadege Atkins, Urmila Bhattacharyya, Marshall Dozier, Jasmin Rostron, Aziz Sheikh, Ruth McQuillan, Evropi Theodoratou Eur Respir Rev, 31 (166) 220066; 10.1183/16000617.0066-2022
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe Constantine I. Vardavas, Alexander G. Mathioudakis, Katerina Nikitara, Kimon Stamatelopoulos, Georgios Georgiopoulos, Revati Phalkey, Jo Leonardi-Bee, Esteve Fernandez, Dolors Carnicer-Pont, Jørgen Vestbo, Jan C. Semenza, Charlotte Deogan, Jonathan E. Suk, Piotr Kramarz, Favelle Lamb, Pasi Penttinen Eur Respir Rev, 31 (166) 220098; 10.1183/16000617.0098-2022
Parasitic lung diseases Jaffar A. Al-Tawfiq, Hojoong Kim, Ziad A. Memish Eur Respir Rev, 31 (166) 220093; 10.1183/16000617.0093-2022
Pulmonary aspergillosis: diagnosis and treatment Frederic Lamoth, Thierry Calandra Eur Respir Rev, 31 (166) 220114; 10.1183/16000617.0114-2022
Severe community-acquired pneumonia Michael S. Niederman, Antoni Torres Eur Respir Rev, 31 (166) 220123; 10.1183/16000617.0123-2022
Nicotine or tobacco abstinence? Rachael L. Murray, Matthew Evison, Matthew E. Callister Eur Respir Rev, 31 (166) 220089; 10.1183/16000617.0089-2022
Reply to: “Nicotine or tobacco abstinence?” Reiner Hanewinkel, Kathrin Niederberger, Anya Pedersen, Jennifer B. Unger, Artur Galimov Eur Respir Rev, 31 (166) 220158; 10.1183/16000617.0158-2022